PremiumThe FlyCMS demands on drug pricing ‘extreme,’ ‘highly problematic,’ says Leerink B. Riley says Novavax Nuvaxovid approval removes regulatory overhang Novavax Stock (NVAX) Shoots 15% Higher as Covid Vaccine Jab Gets FDA Green Light PremiumThe FlySanofi to invest at least $20B in U.S. through 2030 U.S. biotech companies debate relocating trials outside U.S., Reuters reports Trump’s drug-price crackdown may lead to minor concessions, WSJ reports PremiumThe FlyFDA announces expanded use of unannounced inspections at foreign facilities Berenberg says pharma ’emerging from the pill penalty box’ Trump to sign order streamlining U.S. drug manufacturing regulations, WaPo says 
